PUBLIC CONTRACT · 2017
D503 - Dolutegravir + abacavir + lamivudina [50 mg + 600 mg + 300 mg; cáp/comp]
- Contract value
- €442,400.79
- Signed on
- 29 June 2017
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 3725220PUBLISHED DESCRIPTION
AQUISIÇÃO DO MEDICAMENTO D503-DOLUTEGRAVIR + ABACAVIR + LAMIVUDINA [50 MG + 600 MG + 300 MG; CÁP/COMP] DESENCADEADA PELA SPMS, EPE NO ÂMBITO DO DESPACHO 1571/B DE 2016
Parties involved
- Place of performance
- Portugal, Porto, Matosinhos
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- ViiV Healthcare, Unipessoal Lda · Tax ID 509117961
Values and timeline
- Contract price
- €442,400.79
- Procedure base price
- €569,629.50
- Total effective price
- Not reported on Portal BASE
- Publication date
- 29 September 2017
- Award date
- 23 March 2017
- Signing date
- 29 June 2017
- Performance period
- 93 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Not stated
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 24.º, n.º 1, alínea e) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL 18/2008)
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 2935413
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.